132 related articles for article (PubMed ID: 11651972)
1. Cohort-specific consent: an honest approach to phase 1 clinical cancer studies.
Freedman B
IRB; 1990; 12(1):5-7. PubMed ID: 11651972
[No Abstract] [Full Text] [Related]
2. The ethics of phase I pediatric oncology trials.
Ackerman TF
IRB; 1995; 17(1):1-5. PubMed ID: 11653060
[No Abstract] [Full Text] [Related]
3. Enhancing comprehension of information for informed consent: a review of empirical research.
Silva MC; Sorrell JM
IRB; 1988; 10(1):1-5. PubMed ID: 11658988
[No Abstract] [Full Text] [Related]
4. Perspectives of protocol reviewers.
Moline ML; Aisen MW
J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
[No Abstract] [Full Text] [Related]
5. Playing roulette with experimental drugs.
Budiansky S
US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
[No Abstract] [Full Text] [Related]
6. Informed consent: I. The institutional non-liability clause as a liability in recruiting research subjects.
Trice AD; Ogden EP
J Soc Behav Pers; 1986; 1(3):391-6. PubMed ID: 11659090
[No Abstract] [Full Text] [Related]
7. Annual review: observed deficiencies and suggested corrections.
Adams MS; Conrad DA
IRB; 1996; 18(6):1-4. PubMed ID: 11654743
[No Abstract] [Full Text] [Related]
8. Deception and the placebo effect in biomedical research.
Connelly RJ
IRB; 1987; 9(4):5-7. PubMed ID: 11649948
[No Abstract] [Full Text] [Related]
9. The use of placebos in randomized clinical trials.
Levine RJ; Schafer A
IRB; 1985; 7(2):1-6. PubMed ID: 11649622
[No Abstract] [Full Text] [Related]
10. Advantages and drawbacks of the Zelen design for randomized clinical trials.
Horwitz RI; Feinstein AR
J Clin Pharmacol New Drugs; 1980 Jul; 20(7):425-7. PubMed ID: 11658484
[No Abstract] [Full Text] [Related]
11. The doctor's unproven belief and the subject's informed choice: another commentary.
Marquis D; Stephens R; Levine RJ
IRB; 1989; 11(3):8-11. PubMed ID: 11650208
[No Abstract] [Full Text] [Related]
12. How many subjects are required for a study?
McLarty JW; Levine RJ
IRB; 1987; 9(5):1-3. PubMed ID: 11649896
[No Abstract] [Full Text] [Related]
13. The ethical approach to phase II clinical trials in oncology.
Dion S
Drugs Exp Clin Res; 1986; 12(1-2-3):41-2. PubMed ID: 11650153
[No Abstract] [Full Text] [Related]
14. College on Problems of Drug Dependence policy on administering drugs with abuse potential in human research.
College on Problems of Drug Dependence
IRB; 1996; 18(5):5-7. PubMed ID: 11654740
[No Abstract] [Full Text] [Related]
15. What kinds of subjects can understand this protocol?
Levine RJ
IRB; 1984; 6(5):6-8. PubMed ID: 11650664
[No Abstract] [Full Text] [Related]
16. The ethical approach to phase I clinical trials in oncology.
Durry G; Dion S
Drugs Exp Clin Res; 1986; 12(1-2-3):21-2. PubMed ID: 11650152
[No Abstract] [Full Text] [Related]
17. The war on cancer.
Hawkins P
Congr Rec (Dly Ed); 1981 Oct; 127(148):S11610-8. PubMed ID: 11658344
[No Abstract] [Full Text] [Related]
18. Facilitating ethical research: promoting informed choice.
National Council on Bioethics in Human Research (Canada)
NCBHR Commun; 1996 Dec; 7(2 Suppl):i-1-28. PubMed ID: 11660531
[No Abstract] [Full Text] [Related]
19. Toward an informed discussion of informed consent: a review and critique of the empirical studies.
Meisel A; Roth LH
Ariz Law Rev; 1983; 25(2):265-346. PubMed ID: 11658677
[No Abstract] [Full Text] [Related]
20. Toward achieving meaningful informed consent in AIDS vaccine trials with injection-drug users.
Sugarman J
AIDS Public Policy J; 1994; 9(4):167-72. PubMed ID: 11654294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
